Economic evaluation of early administration of prednisolone and/or aciclovir for the treatment of Bell's palsy

25 February 2009

journal article
research article
Published by Oxford University Press (OUP) in Family Practice

Vol. 26 (2) , 137-144
https://doi.org/10.1093/fampra/cmn107

Abstract

Objectives. Bell's palsy (BP), which causes facial paralysis, affects 11–40 people per 100 000 per annum in the UK. Its cause is unknown but as many as 30% of patients have continuing facial disfigurement, psychological difficulties and occasionally facial pain. We present an randomised controlled trial (RCT)-based economic evaluation of the early administration of steroids (prednisolone) and/or antivirals (acyclovir) compared to placebo, for treatment of BP.

Keywords

This publication has 7 references indexed in Scilit:

Early Treatment with Prednisolone or Acyclovir in Bell's Palsy
New England Journal of Medicine, 2007
Multiple imputation: current perspectives
Statistical Methods in Medical Research, 2007
Editorial
Statistical Methods in Medical Research, 2007
Handling Missing Data in Patient-Level Cost-Effectiveness Analysis alongside Randomised Clinical Trials
Applied Health Economics and Health Policy, 2005
Bell's Palsy: The Spontaneous Course of 2,500 Peripheral Facial Nerve Palsies of Different Etiologies
Acta Oto-Laryngologica, 2002
The Health Utilities Index (HUI®) system for assessing health-related quality of life in clinical studies
Annals of Medicine, 2001
Bell's palsy
Postgraduate Medicine, 1991